GTX-101(GeneTx Biotherapeutics)

N/A

Report date: 2022/03/31 17:22:55
NME

Base Information

Drug NameGTX-101(GeneTx Biotherapeutics)
Drug Alias NameGTX-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGenetic transcription inhibitors
TargetsNot applicable
Therapy Area/IndicationsAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTexas A&M Agrilife ResearchTexas A&M University San Antonio
China Registration ClassN/A

Develop Information

Active CompaniesGenetx Biotherapeutics LlcTexas A&M University San AntonioTexas A&M Agrilife Research
Inactive CompaniesN/A
Active IndicationsAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A